Contact   |   Login
Biotechnology Banner Image

Biotechnology

Biotechnology Products

Our group of companies provides comprehensive cellular and molecular biology, toxicology, microbiology, sterility assurance, and biocompatibility services to various companies and research institutions around the globe. We work hand in hand with researchers in multiple distinct industries to help them solve their most difficult problems.

Specifically, our client base ranges from large multinational corporations to small start-up firms within the following major industries:

• Biotechnology
• Cosmetics
• Diagnostics
• Medical Device
• Pharmaceuticals
• Specialty Chemicals

Our group has outstanding quality assurance systems and excellent regulatory compliance practices to ensure the high quality of our testing services. We conduct all tests in accordance with applicable Good Manufacturing Practice (GMP) and, when requested, Good Laboratory Practice (GLP) regulations. All GLP studies are in full compliance with all GLP regulations, as deemed by the appropriate agency (FDA, EPA, OECD, EEC, JMHW, JMAFF). Non-GLP studies for discovery are conducted in the "spirit of GLP," including QA audit and inspection. All studies and propriety information are treated as strictly confidential at all times.

Our international services include both non-GLP/GMP or strictly as a GLP/GMP contract resource for developed or pre-defined protocols. Specifically, our group provides expert services to our clients worldwide in the following major classes:

Major Service Classes†:

Products

Our fundamental mission at Pharmapex's Biotechnology Department (PBD) is helping our clients to maximize the return on their R&D investments. Our group employs state-of-the-art technology in manufacturing world-class products for scientists around the globe. We offer customized and specialty molecular biology reagents as well as a comprehensive range of high quality cytokines and interferons, including hard to find interferon subtypes, monoclonal and polyclonal antibodies and assay kits for life science researchers. Our products provide consistent performance with reliable and reproducible results.



† Not all products and services referred to on this site are available in all countries and our products are subject to different regulatory requirements depending on the country of use. Consequently, certain sections of this site may be indicated as being intended only for users in specific countries. Some of the products may also be marketed under different trade names.

You should not construe anything on this site as a promotion or solicitation for any product or service or for the use of any product or service that is not authorized by the laws and regulations of your country of residence. For inquiries about the availability of any specific product or service in your country, you may simply contact us at biotech@PharmapexUSA.com.



Quick Contact

Press Releases and Selected News:
Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.

Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.

FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.